SEC filingsOct 12, 2026 to Oct 19, 2026: insiders reported 840 purchases and sales across 212 companies.840 insider purchases and sales in 7 daysSee the filings →
HornScout

Company profile

TMCI

Treace Medical Concepts, Inc.
NASDAQHealth Care

Latest close: 3.87 USD · Oct 16, 2026 · 1 year · split-adjusted

On the price, the facts of the public record■Insider buy□Insider sell●Results filed
With an account, also○dividends▲splits◌next earningswith an account

End-of-day prices provided by Twelve Data · One close per session; the series does not update during the trading day.

Latest on record

The most recent facts, as filed.

Up to three of the most recent, checkable facts already loaded on this page, each linked to its source.

  1. Aug 24, 2026Reported purchase · Form 4John T. Treace, Chief Executive Officer · $47.7KOpen the filing ↗
  2. Aug 21, 2026Reported purchase · Form 4John T. Treace, Chief Executive Officer · $21.7KOpen the filing ↗
  3. Aug 20, 2026Reported purchase · Form 4John T. Treace, Chief Executive Officer · $177.2KOpen the filing ↗

In numbers

What this profile holds, counted.

Closes · 1 year250
SEC filings on record42215 flagged findings
Reported transactions (Form 4)73since Jan 12, 2023 · and 3 other holdings
Corporate events (8-K)15since Oct 4, 2021

What the record says

Description, identity and filings, each with its source.

Every block cites its source. The colour of a finding marks its category — which document, who filed it — not how much it matters.

SEC record

SEC dossier

What this company has filed with the SEC, in plain language.

The 25 most recent filings (of 422)

Everything filed

Every SEC filing, newest first, with what it is. Below, each type with its own explanation.

  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 14, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 9.8% · event on Jun 30, 26 · amendment
  • Aug 12, 26Form 4 ↗Insider transaction
  • Aug 12, 26SCHEDULE 13G/A ↗Passive stake · John T. Treace · 19.2% · event on Jun 30, 26 · amendment
  • Insider transaction · 2 Form 4 filingsshow all 2hide
  • Aug 7, 2610-Q ↗Quarterly report
  • Aug 7, 268-K ↗Current report · Results
  • Jul 30, 26SCHEDULE 13G/A ↗Passive stake · BlackRock, Inc. · 1.5% · event on Jun 30, 26 · amendment
  • Jun 12, 26Form 4/A ↗Insider transaction · amendment
  • Insider transaction · 3 Form 4 filingsshow all 3hide
  • May 20, 268-K ↗Current report · Shareholder vote results
  • Insider transaction · 6 Form 4 filingsshow all 6hide
  • May 15, 26SCHEDULE 13G/A ↗Passive stake · Armistice Capital, LLC · 9.8% · event on Mar 31, 26 · amendment
  • May 14, 26Form 4 ↗Insider transaction
  • May 14, 26SCHEDULE 13G ↗Passive stake · BANK OF AMERICA CORP /DE/ · 5.5% · event on Mar 31, 26
  • May 8, 2610-Q ↗Quarterly report

422 filings on record, the oldest from Mar 11, 21.

Listing the 25 most recent filings of the 422 on record.

8-Ks, explained

Structure8Governance7
  • Apr 9, 26GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Dec 18, 25StructureEntered a material agreement+6 more in the same filing8-K 1.01 ↗
  • Nov 6, 25GovernanceA senior executive left or was appointed+2 more in the same filing8-K 5.02 ↗
  • Apr 7, 25GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • Jun 13, 23StructureCompleted an acquisition or disposal+1 more in the same filing8-K 2.01 ↗
  • Feb 23, 23GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Feb 10, 23StructureEntered a material agreement+2 more in the same filing8-K 1.01 ↗
  • Sep 28, 22GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗
  • May 4, 22StructureEntered a material agreement+3 more in the same filing8-K 1.01 ↗
  • Feb 25, 22GovernanceA senior executive left or was appointed8-K 5.02 ↗
  • Oct 4, 21GovernanceA senior executive left or was appointed+1 more in the same filing8-K 5.02 ↗

Corporate events are tracked from 2004-08-23, when the SEC renumbered 8-K items. Earlier filings use an incompatible numbering and are not classified here.

Ownership and control

Schedule 13G: short-form filing

The short form, for holders who meet specific requirements: institutional investors, passive investors without a control purpose, or exempt investors. Asset managers and index funds usually file it.

  • John T. Treace19.2%Jun 30, 26SCHEDULE 13G/A ↗
  • Armistice Capital, LLC9.8%Jun 30, 26SCHEDULE 13G/A ↗2 co-filers on this document — the figure is the largest single stake, not their sum. · 6 earlier filings
  • Neil Gagnon9.6%Dec 31, 25SCHEDULE 13G/A ↗3 co-filers on this document — the figure is the largest single stake, not their sum. · 1 earlier filing
  • BANK OF AMERICA CORP /DE/5.5%Mar 31, 26SCHEDULE 13G ↗
  • Morgan Stanley3.4%Dec 31, 24SCHEDULE 13G/A ↗
show 2 more holdershide

Structured 13D/G data starts 2023-12, when the SEC moved these filings to a machine-readable format. Earlier filings exist but are not parsed here.

SEC record

Insider transactions

Buys and sells reported by officers, directors and major shareholders on SEC Form 4.

Buys and sells

  • Aug 24, 26Buy$48KJohn T. TreaceChief Executive Officer↗
  • Aug 21, 26Buy$22KJohn T. TreaceChief Executive Officer↗
  • Aug 20, 26Buy$177KJohn T. TreaceChief Executive Officer↗
  • Jun 11, 26Buy$93KJohn T. TreaceChief Executive Officer↗
  • Jun 11, 26Buy$40KJohn T. TreaceChief Executive Officer↗
  • Jun 10, 26Buy$59KJohn T. TreaceChief Executive Officer↗
  • Jun 1, 26Buy$178KJohn T. TreaceChief Executive Officer↗
  • May 28, 26Buy$185KJohn T. TreaceChief Executive Officer↗
  • May 27, 26Buy$143KJohn T. TreaceChief Executive Officer↗
  • May 26, 26Buy$13KJohn T. TreaceChief Executive Officer↗
  • May 14, 26Buy$161KJohn T. TreaceChief Executive Officer↗
  • May 13, 26Buy$121KJohn T. TreaceChief Executive Officer↗

There is 1 more transaction in this stretch.

Stock compensation, tax and giftsshow the 27 other transactionshide

Stock compensation, tax withholding, option exercises and gifts. They are listed separately and are not included in the purchase and sale totals. The type describes the transaction, not the filer's intent.

  • Sep 30, 26Taxamount n/aScot Michael ElderChief Legl & Comp Off, CorpSec↗
  • Aug 9, 26Taxamount n/aScot Michael ElderChief Legl & Comp Off, CorpSec↗
  • Aug 9, 26Taxamount n/aMark HairChief Financial Officer↗
  • Aug 9, 26Taxamount n/aSean F. ScanlanChief Innovation Officer↗
  • May 19, 26Compensationamount n/aBetsy Hanna↗
  • May 19, 26Compensationamount n/aLAWRENCE W HAMILTON↗
  • May 19, 26Compensationamount n/aLance A Berry↗
  • May 19, 26Compensationamount n/aDeepti Jain↗
  • May 19, 26Compensationamount n/aJane E Kiernan↗
  • May 19, 26Compensationamount n/aJOHN K BAKEWELL↗
  • Apr 17, 26Taxamount n/aMark HairChief Financial Officer↗
  • Apr 1, 26Compensationamount n/aMark HairChief Financial Officer↗
  • Mar 10, 26Taxamount n/aMark HairChief Financial Officer↗
  • Mar 10, 26Taxamount n/aJohn T. TreaceChief Executive Officer↗
  • Mar 10, 26Taxamount n/aSean F. ScanlanChief Innovation Officer↗
  • Mar 10, 26Taxamount n/aScot Michael ElderChief Legl & Comp Off, CorpSec↗
  • Mar 8, 26Taxamount n/aMark HairChief Financial Officer↗
  • Mar 8, 26Taxamount n/aJohn T. TreaceChief Executive Officer↗
  • Mar 8, 26Taxamount n/aSean F. ScanlanChief Innovation Officer↗
  • Mar 8, 26Taxamount n/aScot Michael ElderChief Legl & Comp Off, CorpSec↗
  • Feb 10, 26Compensation$18KSean F. ScanlanChief Innovation Officer↗
  • Jan 22, 26Taxamount n/aJohn T. TreaceChief Executive Officer↗
  • Jan 22, 26Compensationamount n/aJohn T. TreaceChief Executive Officer↗
  • Jan 22, 26Compensationamount n/aSean F. ScanlanChief Innovation Officer↗
  • Jan 22, 26Taxamount n/aMark HairChief Financial Officer↗
  • Jan 22, 26Compensationamount n/aMark HairChief Financial Officer↗
  • Jan 22, 26Taxamount n/aScot Michael ElderChief Legl & Comp Off, CorpSec↗

The full record holds 230 transactions and goes back to Nov 11, 22.

Its sector and its market

Treace Medical Concepts, Inc. among Health Care companies

The profile shows what is on record. Context and Radar place the company among those of its sector and region.

With an account you also get

  • The four engines — growth, trend, risk and context — each with its word and its score.
  • The risk band and the sector phase.
  • The company's fundamentals and accounts.
  • Watchlist: your list of companies, with the «since you follow it» figure.

The research continues

The profile tells the story. The market sets the scene.

From Treace Medical Concepts, Inc., the path continues in the other areas. Each one is shown with its own example, named in its step.

  1. Place it in its market

    Seven layers of its region's market — rates, credit, stress, liquidity, regime, breadth and sectors — with historical precedents. Public example: Apple and ASML.

    See how Context works →
  2. See what deserves a closer look

    Every morning Radar screens the covered companies through a lens and explains why each candidate made the list. Public example: the lists from Aug 11, 2026.

    See how Radar works →
  3. Keep the why

    Follow Treace Medical Concepts, Inc. in the Watchlist and review what changed since you added it: context, notices and filings. Written theses are coming soon. Public example: Apple.

    See an example review →

Coverage

What sits behind this page.

Where each figure comes from and how far it reaches.

Prices
End-of-day closes provided by Twelve Data. One close per session; not real time. Closes adjusted for splits.
Series quality
250 clean closes in the period.
SEC records
422 documents on file, from Mar 11, 2021 to Oct 2, 2026.
Company description
No description available.
This page
Generated on Oct 19, 2026; refreshed through the day.

Start at your own pace

Explore first. Go deeper with access.

Every company's public profile is open. The full reading — context, Radar, watchlist — is inside, in an invitation-only beta.

Compare plans →
  • No account

    This profile for every company we cover: closing prices with the record's facts on the curve, the SEC file in plain language, insider trades included, and links to its sector and exchange.

  • Pro

    What matters today, with its reason, is free with an account. Pro adds, in the profile, each company's notices and their explanation and the analysis of its insiders; in Radar, all the lenses, which notice each candidate carries, filters by notice type and «no dilution», and the cycle cohort filter; and in Watchlist, more companies and notice changes with their reason.

  • Pro+

    Adds the Lab: test a hypothesis on comparable cohorts before reusing it; and bring your lenses to Radar.

Are the prices real time?

No. It is one close per session, from the provider and with the date shown on the profile; it does not update during the trading day.

Which SEC documents appear here?

Those filed with the SEC by the company, its insiders and its major shareholders, within our coverage: periodic reports (10-K, 10-Q, 20-F), material events (8-K), proposed sale notices (Form 144), insider transactions (Form 4) and stakes above 5% (13D/13G). Each links to the original on EDGAR.

Why does a European company show no SEC records?

It depends on the company: some European issuers file a 20-F or 6-K with the SEC and others don't. The profile shows whatever is on record; when there is nothing, it says so rather than guessing why. Europe does not yet have a common filing archive like EDGAR in the United States. The EU will open its own, ESAP, in July 2027 (managers' transactions arrive in January 2028), and we plan to add it once it is available.

Before forming a view on a company,
read what is on record.

One close per session. The record in plain language. Its sector and its market one link away. Your judgment when deciding.

Access by invitation while the beta lasts. Not advice: the profile shows what is on record; it does not recommend.

Treace Medical Concepts, Inc. (TMCI): stock price history, insider trades and SEC filings — HornScout